1-5 of 5
Authors: Alnawaz Rehemtulla
Journal Article
DNAR-08. THY1 MEDIATES TREATMENT RESISTANCE IN GLIOBLASTOMA THROUGH RAPID REPAIR OF DNA DAMAGE Free
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Pages viii118–viii119, https://doi.org/10.1093/neuonc/noae165.0459
Published: 11 November 2024
Journal Article
TMIC-44. THY1 CONFERS PROLIFERATIVE ADVANTAGES AND THERAPY RESISTANCE WITHIN LOCALIZED NICHES OF GLIOMA Free
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v288, https://doi.org/10.1093/neuonc/noad179.1110
Published: 10 November 2023
Journal Article
CBIO-03. ATRX LOSS IN GLIOMA RESULTS IN EPIGENETIC DYSREGULATION OF CELL CYCLE PHASE TRANSITION Free
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Page ii16, https://doi.org/10.1093/neuonc/noaa215.063
Published: 09 November 2020
Journal Article
GENE-17. ATRX LOSS IN GLIOMA RESULTS IN EPIGENETIC DYSREGULATION OF THE G2/M CHECKPOINT AND SENSITIVITY TO ATM INHIBITION Free
Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Page vi101, https://doi.org/10.1093/neuonc/noz175.419
Published: 11 November 2019
Journal Article
HGG-08. ATRX LOSS IN PEDIATRIC GBM RESULTS IN EPIGENETIC DYSREGULATION OF G2/M CHECKPOINT MAINTENANCE AND SENSITIVITY TO ATM INHIBITION Free
Neuro-Oncology, Volume 21, Issue Supplement_2, April 2019, Page ii88, https://doi.org/10.1093/neuonc/noz036.102
Published: 23 April 2019
